Business Description
Kenvue Inc
NAICS : 811490
SIC : 2842
ISIN : US49177J1025
Description
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 0.85 | |||||
| Debt-to-EBITDA | 3.39 | |||||
| Interest Coverage | 5.2 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 2.44 | |||||
| Beneish M-Score | -2.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.9 | |||||
| 3-Year EBITDA Growth Rate | -4.6 | |||||
| 3-Year EPS without NRI Growth Rate | -2 | |||||
| 3-Year FCF Growth Rate | -4.5 | |||||
| 3-Year Book Growth Rate | -15.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 2.98 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.76 | |||||
| 9-Day RSI | 60.79 | |||||
| 14-Day RSI | 58.37 | |||||
| 6-1 Month Momentum % | 22.9 | |||||
| 12-1 Month Momentum % | 24.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.99 | |||||
| Quick Ratio | 0.68 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 105.42 | |||||
| Days Sales Outstanding | 50.37 | |||||
| Days Payable | 135.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.52 | |||||
| Dividend Payout Ratio | 0.66 | |||||
| Forward Dividend Yield % | 3.58 | |||||
| 5-Year Yield-on-Cost % | 3.52 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | -3.13 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.51 | |||||
| Operating Margin % | 16.49 | |||||
| Net Margin % | 7.23 | |||||
| FCF Margin % | 11.44 | |||||
| ROE % | 10.37 | |||||
| ROA % | 4.11 | |||||
| ROIC % | 8.85 | |||||
| 3-Year ROIIC % | 32.03 | |||||
| ROC (Joel Greenblatt) % | 98.67 | |||||
| ROCE % | 8.9 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 39.47 | |||||
| Forward PE Ratio | 18.6 | |||||
| PE Ratio without NRI | 18.76 | |||||
| PS Ratio | 2.84 | |||||
| PB Ratio | 4.31 | |||||
| Price-to-Free-Cash-Flow | 24.8 | |||||
| Price-to-Operating-Cash-Flow | 18.7 | |||||
| EV-to-EBIT | 26.72 | |||||
| EV-to-Forward-EBIT | 14.95 | |||||
| EV-to-EBITDA | 20.23 | |||||
| EV-to-Forward-EBITDA | 14.39 | |||||
| EV-to-Revenue | 3.32 | |||||
| EV-to-Forward-Revenue | 3.17 | |||||
| EV-to-FCF | 29.04 | |||||
| Earnings Yield (Greenblatt) % | 3.74 | |||||
| FCF Yield % | 4.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:KVUE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kenvue Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 15,475 | ||
| EPS (TTM) ($) | 0.58 | ||
| Beta | 0 | ||
| Volatility % | 33.32 | ||
| 14-Day RSI | 58.37 | ||
| 14-Day ATR ($) | 0.435194 | ||
| 20-Day SMA ($) | 22.1805 | ||
| 12-1 Month Momentum % | 24.35 | ||
| 52-Week Range ($) | 17.67 - 23.55 | ||
| Shares Outstanding (Mil) | 1,915.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kenvue Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kenvue Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kenvue Inc Frequently Asked Questions
What is Kenvue Inc(KVUE)'s stock price today?
The current price of KVUE is $22.93. The 52 week high of KVUE is $23.55 and 52 week low is $17.67.
When is next earnings date of Kenvue Inc(KVUE)?
The next earnings date of Kenvue Inc(KVUE) is 2024-11-07.
Does Kenvue Inc(KVUE) pay dividends? If so, how much?
The Dividend Yield %  of Kenvue Inc(KVUE) is 3.52% (As of Today), Highest Dividend Payout Ratio of Kenvue Inc(KVUE) was 0.66. The lowest was 0.31. And the median was 0.31. The  Forward Dividend Yield % of Kenvue Inc(KVUE) is 3.58%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers